Taken together, our data demonstrate for the first time that inflammation is a strong activator of the NOTCH1 cascade through overexpression of MMP9 and that EPA-FFA could exert a preventive action against this mechanism in CRC. This evidence concerns the gene MMP9 and colorectal carcinoma.